# The Effect of Spironolactone on Acute Kidney Injury in Patients Undergoing Coronary Angiography

> **NCT03329443** · PHASE2 · COMPLETED · sponsor: **Alhasan Mujtaba Abdul-Wahid** · enrollment: 490 (actual)

## Conditions studied

- Acute Kidney Injury
- IHD
- Contrast-induced Nephropathy

## Interventions

- **DRUG:** Spironolactone
- **DRUG:** Placebo Oral Tablet

## Key facts

- **NCT ID:** NCT03329443
- **Lead sponsor:** Alhasan Mujtaba Abdul-Wahid
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-01
- **Primary completion:** 2018-09-01
- **Final completion:** 2018-09-04
- **Target enrollment:** 490 (ACTUAL)
- **Last updated:** 2018-09-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03329443

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03329443, "The Effect of Spironolactone on Acute Kidney Injury in Patients Undergoing Coronary Angiography". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03329443. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*